<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Stock Blog Hub &#187; Ariad Pharmaceuticals Inc</title>
	<atom:link href="http://www.stockbloghub.com/tag/ariad-pharmaceuticals-inc/feed" rel="self" type="application/rss+xml" />
	<link>http://www.stockbloghub.com</link>
	<description>Start Your Investing Research Here!</description>
	<lastBuildDate>Mon, 21 May 2012 16:42:30 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>(AAPL) Stock Market News for Jan 19, 2011  &#8211; Market News</title>
		<link>http://www.stockbloghub.com/2011/01/19/aapl-stock-market-news-for-jan-19-2011-market-news/65375</link>
		<comments>http://www.stockbloghub.com/2011/01/19/aapl-stock-market-news-for-jan-19-2011-market-news/65375#comments</comments>
		<pubDate>Wed, 19 Jan 2011 23:13:05 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Personal Computers]]></category>
		<category><![CDATA[Technology]]></category>
		<category><![CDATA[AAPL]]></category>
		<category><![CDATA[Apple Inc.]]></category>
		<category><![CDATA[ARIA]]></category>
		<category><![CDATA[Ariad Pharmaceuticals Inc]]></category>
		<category><![CDATA[BA]]></category>
		<category><![CDATA[BAC]]></category>
		<category><![CDATA[Bank of America Corporation]]></category>
		<category><![CDATA[Boeing Company]]></category>
		<category><![CDATA[C]]></category>
		<category><![CDATA[CAT]]></category>
		<category><![CDATA[Caterpillar Inc.]]></category>
		<category><![CDATA[CF]]></category>
		<category><![CDATA[CF Industries Holdings Inc.]]></category>
		<category><![CDATA[Citigroup Inc.]]></category>
		<category><![CDATA[CMA]]></category>
		<category><![CDATA[Comerica Incorporated]]></category>
		<category><![CDATA[Convergys Corporation]]></category>
		<category><![CDATA[CVG]]></category>
		<category><![CDATA[DAL]]></category>
		<category><![CDATA[Delta Air Lines Inc.]]></category>
		<category><![CDATA[Devon Energy Corporation]]></category>
		<category><![CDATA[DVN]]></category>
		<category><![CDATA[IBM]]></category>
		<category><![CDATA[International Business Machines]]></category>
		<category><![CDATA[Morgan Stanley]]></category>
		<category><![CDATA[MS]]></category>
		<category><![CDATA[TIE]]></category>
		<category><![CDATA[Titanium Metals Corporation]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=65375</guid>
		<description><![CDATA[Investors’ optimism helped markets close higher as stocks continued to gain momentum after an upbeat manufacturing report released by the Federal Reserve Bank of New York. The report helped energy and material share prices to go up despite weak Citigroup results and sliding prices of Apple (NASDAQ:AAPL). In the absence of any other major economic news which could sway the markets, the Dow posted a new 52-week intraday high. The S&#38;P 500 and the tech driven Nasdaq also made gains and stopped just short of recording new 52-week highs. The Dow Jones Industrial Average rose by 0.43% to 11,837.93. The S&#38;P 500 added 0.14% to 1,295.02. The tech laden, Nasdaq Composite Index rose 0.38%, to 2,765.85. On the New York Stock Exchange, advancing stocks at 1,626 were clearly the gainers ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2011/01/19/aapl-stock-market-news-for-jan-19-2011-market-news/65375/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ARIA) ARIAD Pharmaceuticals Reports In-Line Quarter</title>
		<link>http://www.stockbloghub.com/2010/03/18/aria-ariad-pharmaceuticals-reports-in-line-quarter/30917</link>
		<comments>http://www.stockbloghub.com/2010/03/18/aria-ariad-pharmaceuticals-reports-in-line-quarter/30917#comments</comments>
		<pubDate>Thu, 18 Mar 2010 21:05:24 +0000</pubDate>
		<dc:creator>vitalstocks</dc:creator>
				<category><![CDATA[Biotechnology]]></category>
		<category><![CDATA[Healthcare]]></category>
		<category><![CDATA[ARIA]]></category>
		<category><![CDATA[Ariad Pharmaceuticals Inc]]></category>
		<category><![CDATA[Merck & Company Inc]]></category>
		<category><![CDATA[MRK]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=30917</guid>
		<description><![CDATA[ARIAD Pharmaceuticals Inc.’s (ARIA) fourth quarter fiscal 2009 net loss per share came in at 17 cents, identical to the Zacks Consensus Estimate. The year-ago loss was 24 cents. Quarterly Results ARIAD does not have any product in the market. The entire revenue comes from licensing and partnerships. Revenue in the reported quarter stood at $2.15 million as against $2.6 million in the year-ago quarter. Operating expenses climbed 5.5% to approximately $20.5 million in the reported quarter. The company has made significant progress towards developing its lead pipeline candidates ridaforolimus and AP24534. Ridaforolimus is being co-developed with Merck &#38; Co. (MRK) as a treatment for cancer. Ariad intends to present complete results from the late-stage studies of ridaforolimus in the fourth quarter of 2010. The significant pipeline development in addition ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2010/03/18/aria-ariad-pharmaceuticals-reports-in-line-quarter/30917/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>(ASH) Investing in the Biotech Sector: Here’s An Easy Way to Profit from Biotech Stocks</title>
		<link>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305</link>
		<comments>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305#comments</comments>
		<pubDate>Wed, 11 Nov 2009 21:51:36 +0000</pubDate>
		<dc:creator>InvestmentU</dc:creator>
				<category><![CDATA[Basic Materials]]></category>
		<category><![CDATA[Chemicals - Major Diversified]]></category>
		<category><![CDATA[ARIA]]></category>
		<category><![CDATA[Ariad Pharmaceuticals Inc]]></category>
		<category><![CDATA[ASH]]></category>
		<category><![CDATA[Ashland Inc.]]></category>
		<category><![CDATA[Biomarin Pharmaceutical Inc]]></category>
		<category><![CDATA[BMRN]]></category>
		<category><![CDATA[BMY]]></category>
		<category><![CDATA[Bristol-Myers Squibb Company]]></category>
		<category><![CDATA[CELG]]></category>
		<category><![CDATA[Celgene Corporation]]></category>
		<category><![CDATA[IMGN]]></category>
		<category><![CDATA[Immunogen Inc]]></category>
		<category><![CDATA[JPM]]></category>
		<category><![CDATA[JPMorgan Chase & Company]]></category>
		<category><![CDATA[PARD]]></category>
		<category><![CDATA[Poniard Pharmaceuticals Inc]]></category>
		<category><![CDATA[SuperGen Inc]]></category>
		<category><![CDATA[SUPG]]></category>

		<guid isPermaLink="false">http://www.stockbloghub.com/?p=20305</guid>
		<description><![CDATA[by Marc Lichtenfeld, Healthcare Expert Wednesday, November 11, 2009: Issue #1135 Investing in the biotech sector can be risky – no doubt about that. But you know what? There are a lot of ways to make money from biotech stocks, too. If you know what to look for, that is. Two obvious examples include: Picking the company behind the next breakthrough drug for cancer or Alzheimer’s. Digging out companies that are likely takeover targets (something my colleague Louis Basenese does expertly in his Takeover Trader service), or landing lucrative drug partnership deals, which send the stocks higher. But there’s another excellent way that shorter-term investors can grab gains and profit from biotech sector… Follow the Biotech Sector Conference Buzz Throughout the year, the biotech sector holds many key conferences where ]]></description>
		<wfw:commentRss>http://www.stockbloghub.com/2009/11/11/ash-investing-in-the-biotech-sector-here%e2%80%99s-an-easy-way-to-profit-from-biotech-stocks/20305/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

